Women on weight-loss medication may have a lower risk of developing breast cancer, according to a new study.

Three studies add to evidence that jabs could be part of cancer-fighting toolkit to cut risk of developing or dying from disease

Weight loss jabs could significantly lower the risk of breast cancer , even in those considered at high risk of the disease, a landmark study has suggested.

Un estudio observacional con más de 110 000 mujeres abre la puerta a utilizar estos populares medicamentos para la pérdida de peso como prevención oncológica.

About 42,140 women are expected to die from breast cancer in the U.S. this year

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleWeight-loss jabs have risen in popularity…

Weight-loss drugs may reduce breast cancer risk by up to 30%, according to three studies, highlighting their potential role in lowering cancer development and mortality rates.

A new study of more than 111,000 women ages 45 to 80 found those on GLP-1 medications had a reduced risk of developing breast cancer by about 30%.

More than two dozen studies suggest the treatments are linked to lower cancer risk, reduced metastasis and improved survival, though researchers say trials are needed to confirm…

Secondo un nuovo studio, le donne che assumono farmaci dimagranti potrebbero avere un rischio inferiore di sviluppare un tumore al seno.

Secondo un nuovo studio, le donne che assumono farmaci dimagranti potrebbero avere un rischio inferiore di sviluppare il tumore al seno.

Women on weight-loss medication may have a lower risk of developing breast cancer, according to a new study.